Sign In
Buy BAX
$18.54
-0.140 (-0.749%)
At Close: Jun 03, 2026
Baxter International: Hillrom Acquisition Could Be A Tailwind For FCF
07:02pm, Monday, 12'th Jun 2023
Baxter International Inc plans to divest its BioPharma Solutions business for $4.25 billion, aiming to pay down its long-term debt and create room for further growth. The company's robust margins and
Baxter to Present at Jefferies Healthcare Conference
04:15pm, Wednesday, 24'th May 2023
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the Jefferies Healthcare Conference on Thursday, June 8, 2023. José (Joe) Almeida, Bax
Shares of Baxter International Inc. BAX rose 1.2% in premarket trading Monday, after the health care products company announced an agreement to divest its BioPharma Solutions business to private-equit
BAX vs. SYK: Which Stock Should Value Investors Buy Now?
12:57pm, Tuesday, 02'nd May 2023
Investors interested in stocks from the Medical - Products sector have probably already heard of Baxter International (BAX) and Stryker (SYK). But which of these two stocks is more attractive to value
Baxter International Inc. (BAX) Q1 2023 Earnings Call Transcript
12:11pm, Thursday, 27'th Apr 2023
Baxter International Inc. (BAX) Q1 2023 Earnings Call Transcript.
Are Investors Undervaluing Baxter International (BAX) Right Now?
11:29am, Tuesday, 25'th Apr 2023
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
Baxter (BAX) to Post Q1 Earnings: What's in the Offing?
08:23am, Thursday, 20'th Apr 2023
Baxter's (BAX) first-quarter results are likely to reflect growth in elective surgical procedures, offset by currency movement. Hillrom's products might have boosted sales.
Baxter to Present at BofA Securities 2023 Health Care Conference
04:15pm, Wednesday, 19'th Apr 2023
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the BofA Securities 2023 Health Care Conference on Tuesday, May 9, 2023. Jay Saccaro, B
3 Reasons To Consider A Nibble On Baxter
02:43pm, Tuesday, 11'th Apr 2023
H1-23 is likely to be challenging, but drastic adjustments have already been made to forward estimates, with valuations now looking attractive. FCF could double in FY23 as working capital dynamics pic
Baxter's (BAX) New Premix Drug Now Available in the U.S.
12:56pm, Monday, 10'th Apr 2023
Baxter's (BAX) latest frozen premix formulation is expected to support patient safety, simplify medication preparation and boost operational efficiencies.
Baxter to Host First-Quarter 2023 Financial Results Conference Call for Investors
04:15pm, Thursday, 06'th Apr 2023
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, will host a conference call to discuss its first-quarter 2023 financial results on Thursday, April 27,
Dividend Champion, Contender, And Challenger Highlights: Week Of March 26
10:44am, Saturday, 25'th Mar 2023
A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends.
Exclusive: Thermo Fisher, Celltrion vie for Baxter's biopharma unit -sources
05:43pm, Monday, 20'th Mar 2023
U.S. scientific instruments maker Thermo Fisher Scientific Inc and South Korea's Celltrion Inc are among
Is It Time to Buy the S&P 500's 4 Worst-Performing Stocks of 2023?
07:38am, Sunday, 05'th Mar 2023
Lumen's slowing growth, high debt, and dividend cut spooked the bulls. Moderna and Pfizer both face tough post-pandemic slowdowns.
Dividend Champion, Contender, And Challenger Highlights: Week Of February 19
02:13am, Sunday, 19'th Feb 2023
A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends.
